{
  "variant_id": {
    "Gene": "LRRK2",
    "Protein_Change": {
      "ref": "I",
      "alt": "T",
      "position": "238"
    },
    "variant_string_id": "LRRK2 I238T"
  },
  "functional_evidence_aim": "Pathogenic",
  "assessment_steps": [
    {
      "step_name": "Step 1: Define the disease mechanism",
      "extracted_paper_info": "The paper states that LRRK2 kinase activity is a critical mechanism in Parkinson's disease, and the I238T variant impairs this activity.",
      "judgment": "Yes",
      "reasoning": "The paper explicitly links LRRK2 kinase activity to Parkinson's disease pathogenesis and demonstrates that I238T impairs this activity."
    },
    {
      "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
      "extracted_paper_info": "The study used kinase activity assays, which are a standard class of assay for evaluating LRRK2 function in Parkinson's disease.",
      "judgment": "Yes",
      "reasoning": "Kinase activity assays are widely accepted in the field as relevant to LRRK2's role in Parkinson's disease.",
      "next_step_or_outcome": "Proceed to Step 3"
    },
    {
      "step_name": "Step 3a: Basic Controls and Replicates",
      "extracted_paper_info": "The paper includes wild-type and pathogenic variant controls (e.g., G2019S) and reports experiments performed in triplicate.",
      "judgment": "Yes",
      "reasoning": "Both wild-type and pathogenic control variants are used, and experiments are repeated in triplicate, meeting the criteria for basic controls and replicates.",
      "next_step_or_outcome": "Proceed to Step 3c"
    },
    {
      "step_name": "Step 3c: Variant Controls",
      "extracted_paper_info": "The study uses known pathogenic variants (e.g., G2019S) as controls for comparison with I238T.",
      "judgment": "Yes",
      "reasoning": "Known pathogenic variants are used as controls, which strengthens the validity of the assay.",
      "next_step_or_outcome": "Proceed to Step 4"
    },
    {
      "step_name": "Step 4a: Statistical Analyses",
      "extracted_paper_info": "The paper reports statistical significance (p < 0.05) and effect sizes for the I238T variant's impact on kinase activity.",
      "judgment": "Yes",
      "reasoning": "Robust statistical analysis is provided, enabling the estimation of OddsPath.",
      "next_step_or_outcome": "Proceed to Step 4c"
    },
    {
      "step_name": "Step 4c: Correlate OddsPath",
      "extracted_paper_info": "The study demonstrates a significant reduction in kinase activity for I238T compared to wild-type, with statistical significance and comparison to known pathogenic variants.",
      "judgment": "Yes",
      "reasoning": "The functional data strongly support a pathogenic effect, aligning with ACMG criteria for PS3_moderate."
    }
  ],
  "final_evidence_strength": {
    "type": "Pathogenic",
    "strength": "PS3_moderate"
  },
  "overall_conclusion": "The I238T variant in LRRK2 impairs kinase activity, a key disease mechanism in Parkinson's disease, with robust controls, replicates, and statistical significance. This provides moderate PS3 evidence for pathogenicity."
}